Asterias Biotherapeutics Reports Preclinical Data On AST-OPC1 For Treatment Of Subacute Cervical Spinal Cord Injury Published In Peer-Reviewed Publication Consistent With Early Data Read-Outs From Ongoing SCIStar Phase 1/2a Trial